GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (MEX:SAVA) » Definitions » E10

Cassava Sciences (MEX:SAVA) E10 : MXN-35.88 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Cassava Sciences E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cassava Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was MXN-7.136. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-35.88 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -40.60% per year. During the past 5 years, the average E10 Growth Rate was -11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cassava Sciences was 36.70% per year. The lowest was -40.60% per year. And the median was -1.60% per year.

As of today (2024-06-25), Cassava Sciences's current stock price is MXN356.00. Cassava Sciences's E10 for the quarter that ended in Mar. 2024 was MXN-35.88. Cassava Sciences's Shiller PE Ratio of today is .


Cassava Sciences E10 Historical Data

The historical data trend for Cassava Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences E10 Chart

Cassava Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -14.42 -18.31 -42.14

Cassava Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.40 -17.19 -26.88 -42.14 -35.88

Competitive Comparison of Cassava Sciences's E10

For the Biotechnology subindustry, Cassava Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cassava Sciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cassava Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cassava Sciences's Shiller PE Ratio falls into.



Cassava Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cassava Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-7.136/131.7762*131.7762
=-7.136

Current CPI (Mar. 2024) = 131.7762.

Cassava Sciences Quarterly Data

per share eps CPI Adj_EPS
201406 -6.355 100.560 -8.328
201409 -7.519 100.428 -9.866
201412 -5.162 99.070 -6.866
201503 -6.403 99.621 -8.470
201506 -7.688 100.684 -10.062
201509 -9.463 100.392 -12.421
201512 -12.037 99.792 -15.895
201603 -15.665 100.470 -20.546
201606 -8.507 101.688 -11.024
201609 -10.441 101.861 -13.507
201612 -8.659 101.863 -11.202
201703 -7.908 102.862 -10.131
201706 -11.569 103.349 -14.751
201709 -7.259 104.136 -9.186
201712 -7.267 104.011 -9.207
201803 -5.995 105.290 -7.503
201806 -7.074 106.317 -8.768
201809 -2.058 106.507 -2.546
201812 -0.785 105.998 -0.976
201903 -1.552 107.251 -1.907
201906 -1.153 108.070 -1.406
201909 -0.790 108.329 -0.961
201912 -1.509 108.420 -1.834
202003 -1.172 108.902 -1.418
202006 -1.154 108.767 -1.398
202009 -1.325 109.815 -1.590
202012 -1.790 109.897 -2.146
202103 -1.840 111.754 -2.170
202106 -2.588 114.631 -2.975
202109 -4.935 115.734 -5.619
202112 -7.180 117.630 -8.044
202203 -8.761 121.301 -9.518
202206 -9.657 125.017 -10.179
202209 -10.259 125.227 -10.796
202212 -9.163 125.222 -9.643
202303 -10.454 127.348 -10.818
202306 -10.801 128.729 -11.057
202309 -10.626 129.860 -10.783
202312 -8.487 129.419 -8.642
202403 -7.136 131.776 -7.136

Add all the adjusted EPS together and divide 10 will get our e10.


Cassava Sciences  (MEX:SAVA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cassava Sciences E10 Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cassava Sciences (MEX:SAVA) Business Description

Traded in Other Exchanges
Address
6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Cassava Sciences (MEX:SAVA) Headlines

From GuruFocus

New Publication Highlights Basic Science Supporting Simufilam

By sperokesalga sperokesalga 06-12-2023